Kairos Power test reactor comes to repurposed Oak Ridge site

December 11, 2020, 2:41PMNuclear News

An aerial view of the ETTP site. Photo: Heritage Center, LLC

Kairos Power plans to site a test reactor it has dubbed Hermes at the East Tennessee Technology Park (ETTP) in Oak Ridge, Tenn. The company has executed a Memorandum of Understanding with Heritage Center, LLC, to acquire the former K-33 gaseous diffusion plant site at ETTP, subject to ongoing due diligence evaluations. The announcement was made today, during the 2020 East Tennessee Economic Council Annual Meeting and Awards Celebration.

“We are thrilled at the prospect of coming to East Tennessee,” said Michael Laufer, cofounder and chief executive officer of Kairos Power. “The infrastructure available at ETTP, combined with its proximity to key collaborators at the Oak Ridge National Laboratory, makes this a great location to demonstrate our technology. The successful commissioning of Hermes builds on our current technology development programs and extensive engagement with the U.S. Nuclear Regulatory Commission. Ultimately, Hermes will prove that Kairos Power can deliver real systems at our cost targets to make advanced nuclear a competitive source of clean energy in the United States.”

Lou Martinez, vice president of strategy and innovation, added, “Today is an important day for Kairos Power. We are celebrating our 4th anniversary by showcasing an important milestone.”

To continue reading, log in or create a free account!

Related Articles

Buyers Guide celebrates 55 years

March 15, 2024, 7:00AMNuclear News

The newest edition of the Nuclear News Buyers Guide will be out soon, marking the 55th year of the most comprehensive goods and services publication in the nuclear industry. The American...

Taking aim at disease

Radioisotopes target cancer, improve imaging, and have myriad other medical uses

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...